Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
15.8%
% of HELX's 68 holdings also in XDNA
39.1%
% of XDNA's 23 holdings also in HELX
Overlap by Weight
Sector Drift (HELX minus XDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HELX |
Weight in XDNA |
Overlap | |
---|---|---|---|---|
THERMO FISHER SCIENTIFIC INC | 6.2% | 9.5% | 6.2% | |
AGILENT TECHNOLOGIES INC | 2.1% | 2.7% | 2.1% | |
INTELLIA THERAPEUTICS, INC. | 1.5% | 8.7% | 1.5% | |
VERTEX PHARMACEUTICALS INC | 4.8% | 1.5% | 1.5% | |
REGENERON PHARMACEUTICALS | 4.6% | 1.3% | 1.3% |
Position Highlights (Non-Overlapping Exposures)
HELX Overweight Relative to XDNA
MEDPACE HOLDINGS, INC. | 8.0% | |
DANAHER CORP | 5.4% | |
ELI LILLY & CO | 4.2% | |
KRYSTAL BIOTECH, INC. | 3.7% | |
REGENERON PHARMACEUTICALS | 3.4% | |
VERTEX PHARMACEUTICALS INC | 3.3% | |
BRUKER CORP | 3.2% | |
SARTORIUS AG PREF | 3.1% | |
SAMSUNG BIOLOGICS CO., LTD. | 2.9% | |
IONIS PHARMACEUTICALS, INC. | 2.7% |
HELX Underweight Relative to XDNA
CRISPR THERAPEUTICS AG | -14.3% | |
BEAM THERAPEUTICS, INC. | -13.0% | |
INTELLIA THERAPEUTICS, INC. | -7.2% | |
PRIME MEDICINE, INC. | -5.9% | |
EDITAS MEDICINE, INC. | -5.7% | |
CARIBOU BIOSCIENCES, INC. | -4.7% | |
VERVE THERAPEUTICS, INC. | -4.5% | |
POSEIDA THERAPEUTICS, INC. | -4.1% | |
ABBVIE INC | -3.8% | |
ALLOGENE THERAPEUTICS, INC. | -3.4% |